infomeddnews

Verve Medical Treats First Patient in Landmark U.S. Pilot Trial for Uncontrolled Hypertension, Advancing Momentum from Breakthrough TUSK Results

Verve Medical, the leader in non‑invasive renal pelvic denervation (RPD) technology, today announced successful treatment of the first patient in its randomized, double‑blinded U.S. pilot clinical ...
infomeddnews

Terumo Launches SurTract™ Safety Syringe in the United States, Powered by Roncadelle Operations’ SafeR® Passive Safety Technology

The SurTract Syringe will be distributed across hospitals, clinics, and emergency-care settings beginning in the first quarter of 2026. Terumo Medical Corporation, a wholly-owned subsidiary of Terumo ...
infomeddnews

How Executive Skills Transform Local Governance

Executive leadership and neighborhood organizing seem to occupy different worlds. One involves strategic planning, financial analysis, and corporate governance. The other centers on community meetings ...
infomeddnews

Mopec Group Introduces Cortex Systems to Advance Connected Pathology Workflows

Mopec Group, a diversified pathology solutions leader serving the pathology continuum, today announced the evolution of its technology division by introducing Cortex Systems. This evolution formalizes ...
infomeddnews

MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism

MBX Biosciences, Inc. today announced the successful completion of an End-of-Phase 2 (EOP2) meeting with the U.S. Food and Drug Administration (FDA) to discuss the overall Phase 3 trial design for ...
infomeddnews

Clinical Labs Review Proposed Legislation To Modernize Oversight of Lab-Developed Tests Under CLIA

"This is an important proposal that will hopefully spark crucial conversations across the clinical laboratory community," said Jonathan Genzen, MD, PhD, MBA, chief medical officer and senior director ...
infomeddnews

PathoQuest, a Kurma Partners portfolio company, announces a definitive agreement to be acquired by Charles River Laboratories

PathoQuest was built and supported by Kurma Partners and the Pasteur Institute and based on the groundbreaking work of Prof. Marc Eloit PathoQuest, a Kurma Partners portfolio company, pioneer and ...
infomeddnews

Variational AI Releases Enki 4: Major Update to Foundation Model for Small-Molecule Drug Discovery

Variational AI introduces Enki™ 4: an improved algorithm and architecture designed to scale, expanding the pre-trained target coverage from 592 to 760 and now applicable to proximity-based ...
infomeddnews

Mount Sinai Medical Center Named One of America’s 100 Best Hospitals

Mount Sinai Medical Center announced today that it is one of America’s 100 Best Hospitals for 2026, according to new research released by Healthgrades, the #1 site Americans use when searching for a ...
infomeddnews

ACC Announces Inaugural Fellow for the Thad and Gerry Waites Rural Cardiovascular Research Fellowship

The American College of Cardiology will recognize Plicy Perez-Kersey, MD, as the first recipient of the Thad and Gerry Waites Rural Cardiovascular Research Fellowship Award. Perez-Kersey will be ...
infomeddnews

ACU-Serve Names Natasha Baria Mehta President to Lead Next Phase of Strategic Growth

ACU-Serve announced the appointment of Natasha Baria Mehta as President, a strategic leadership addition that reflects the company’s continued investment in growth, operational excellence, and ...
infomeddnews

Ingenix Raises €13m From Sofinnova Partners-Led Syndicate to Scale Modality Fusion, a Novel Architecture for Drug Development

Ingenix, the AI and biology company built around a single question – “What would it take for AI to truly understand biology?” – has today announced a €13m seed-extension funding round led by Sofinnova ...